filmov
tv
The use of ctDNA for molecular residual disease assessment and Immunotherapy Monitoring in NSCLC
Показать описание
OMNIConnect
Рекомендации по теме
0:01:10
Dr. Ocean Discusses the Use of ctDNA in Pancreatic Cancer
0:02:05
Challenges to be overcome in the use of ctDNA for colon cancer treatment
0:02:26
Dr. Goetz on the Use of ctDNA in the MONARCH-3 Trial in HR+/HER2- Breast Cancer
0:04:06
The use of ctDNA assays in patients with cancer
0:04:26
Fundamentals of ctDNA
0:08:18
The use of ctDNA in patient cancer care
0:02:06
Applications of ctDNA in oncology
0:03:16
The utility of ctDNA in colorectal cancer management
0:00:45
The emerging role of ctDNA in cancer diagnostics
0:01:23
Role of ctDNA in MRD
0:46:19
The use of ctDNA for molecular residual disease assessment and Immunotherapy Monitoring in NSCLC
0:03:32
The role of ctDNA in lung cancer screening
0:01:16
Dr. Nallapareddy on the Use of ctDNA Testing in Colorectal Cancer
0:03:07
Future uses of ctDNA measurements: changing the treatment landscape
0:01:26
Potential role of ctDNA for early-stage breast cancer
0:00:40
Expanding the use of ctDNA in clinical trials
0:03:44
Evaluating the use of ctDNA as a biomarker in lung cancer
0:02:03
ctDNA and MRD—How, When, and on Who Do We Use It | Kristen Ciombor, MD | ESMO22 Pennsylvania
0:03:41
CIRCULATE-US: investigating the use of ctDNA to detect MRD
0:13:28
What is ctDNA? How is it Helpful?
0:01:36
The use of ctDNA in identifying post-surgical CRC residual disease status
0:03:24
Circulating Tumor DNA (ctDNA) and liquid biopsy
1:25:24
Expediting Drug Development: Use of ctDNA as an Early Endpoint
0:09:35
Methods for ctDNA detection and analysis
0:01:10
0:02:05
0:02:26
0:04:06
0:04:26
0:08:18
0:02:06
0:03:16
0:00:45
0:01:23
0:46:19
0:03:32
0:01:16
0:03:07
0:01:26
0:00:40
0:03:44
0:02:03
0:03:41
0:13:28
0:01:36
0:03:24
1:25:24
0:09:35